Date Filed | Type | Description |
04/11/2017 |
GN
| MonoSol Rx Appoints James S. Scibetta to Board of Directors |
05/12/2008 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2008 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 5.2% stake in BIOENVISION, INC. |
10/26/2007 |
SC 13D/A
| LEHMAN BROTHERS HOLDINGS INC reports a 0% stake in BIOENVISION, INC. |
10/25/2007 |
SC 13D/A
| LEHMAN BROTHERS HOLDINGS INC reports a 0% stake in BIOENVISION, INC. |
10/24/2007 |
SC 13D/A
| GENZYME CORP reports a 100% stake in BIOENVISION, INC. |
10/11/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
10/11/2007 |
8-K
| Quarterly results |
10/10/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
10/10/2007 |
8-K
| Other Events, Financial Statements and Exhibits |
10/05/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
10/05/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
10/04/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
10/01/2007 |
SC 13D/A
| SCO CAPITAL PARTNERS LLC reports a 13.1% stake in BIOENVISION, INC. |
09/27/2007 |
SC 13D/A
| GENZYME CORP reports a 27.9% stake in BIOENVISION, INC. |
09/20/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
09/19/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
09/12/2007 |
10-K
| Annual Report for the period ended June 30, 2007 |
09/12/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
09/12/2007 |
SC 13D/A
| SCO CAPITAL PARTNERS LLC reports a 13.1% stake in BIOENVISION, INC. |
09/12/2007 |
8-K
| Quarterly results |
09/07/2007 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
09/06/2007 |
SC 13D/A
| ELLIOTT ASSOCIATES, L.P. reports a 4% stake in Bioenvision, Inc. |
08/31/2007 |
8-K
| Other Events |
08/22/2007 |
SC 13G
| EDELMAN JOSEPH reports a 12.1% stake in Bioenvision, Inc. |
08/16/2007 |
8-K
| Other Events, Financial Statements and Exhibits |
08/06/2007 |
SC 13D
| ELLIOTT ASSOCIATES, L.P. reports a 3.5% stake in Bioenvision, Inc. |
08/02/2007 |
4/A
| GENZYME CORP (10% Owner) has filed a Form 4 on BIOENVISION INC |
08/02/2007 |
SC 13D/A
| GENZYME CORP reports a 27.9% stake in BIOENVISION, INC. |
07/30/2007 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
07/27/2007 |
8-K
| Other Events, Financial Statements and Exhibits |
07/17/2007 |
SC 13D/A
| GENZYME CORP reports a 28.2% stake in BIOENVISION, INC. |
07/16/2007 |
4/A
| GENZYME CORP (10% Owner) has filed a Form 4 on BIOENVISION INC |
07/16/2007 |
SC 13D/A
| GENZYME CORP reports a 28.2% stake in BIOENVISION, INC. |
|